← Back
Data updated: Mar 10, 2026
GENUS
OncologyMetabolic
GENUS is a generic drug manufacturer focused on Oncology, Metabolic. Key products include POKONZA.
1943
Since
20
Drugs
-
Trials
249
Approved (2yr)
Recent Activity
NYSTATIN 2026-02-05
CHLORPROMAZINE HYDROCHLORIDE 2026-01-26
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2026-01-08
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2025-12-31
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2025-12-31
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2025-12-31
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2025-12-31
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2025-12-31
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2025-12-31
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2025-12-31
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 81%
0 drugs Phase 3: 1 Phase 2: 6 Phase 1: 10
Metabolic 19%
1 drugs
Pipeline Strength Pro
Loading...
Active (8)
Discontinued (12)
CHLORPROMAZINE HYDROCHLORIDE HYDROCODONE BITARTRATE AND ACETAMINOPHEN MEPERIDINE HYDROCHLORIDE POTASSIUM CHLORIDE METOCLOPRAMIDE HYDROCHLORIDE ISOSORBIDE MONONITRATE ISONIAZID CARISOPRODOL AND ASPIRIN TIVORBEX SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE CLEMASTINE FUMARATE HYDROCORTISONE ACETATE 1% AND PRAMOXINE HYDROCHLORIDE 1%
Company Info
- First Approval
- 1943-03-23
- Latest
- 2025-12-22
- Applications
- 24